ETR:CCAP CORESTATE Capital (CCAP) Stock Price, News & Analysis €0.28 +0.00 (+1.48%) As of 07/4/2025 Add Compare Share Share Stock Analysis Stock AnalysisChartBuy This Stock About CORESTATE Capital Stock (ETR:CCAP) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get CORESTATE Capital alerts:Sign Up Key Stats Today's Range€0.27▼€0.2950-Day Range€0.24▼€0.2952-Week Range€0.26▼€0.76Volume19,772 shsAverage VolumeN/AMarket Capitalization€45.60 millionP/E RatioN/ADividend Yield909.09%Price TargetN/AConsensus RatingN/A Company Overview CORESTATE Capital Holding S.A. is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments. The firm offers investment products in real estate funds, co-investments, and club deals. It prefers to invest in Central Europe, Austria, Switzerland, and Germany. CORESTATE Capital Holding S.A. was founded in 2006 and is based in Luxembourg, Luxembourg with additional offices in Zug, Switzerland; London, United Kingdom; Frankfurt, Germany; and Singapore. CORESTATE Capital Holding S.A. operates as a subsidiary of Flygon Holding LLC. Read More Receive CCAP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CORESTATE Capital and its competitors with MarketBeat's FREE daily newsletter. Email Address CCAP Stock News HeadlinesCorestate Capital Holding S.A.May 27, 2025 | barrons.comEQS-Adhoc: Corestate Capital Holding S.A.: Corestate to sell STAM Europe SASApril 10, 2025 | markets.businessinsider.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal. | Brownstone Research (Ad)Corestate Capital Holding SANovember 9, 2024 | morningstar.comMWells Fargo Sticks to Its Hold Rating for Crescent Capital BDC (CCAP)October 29, 2024 | markets.businessinsider.comLadenburg Thalmann Initiates Coverage of Crescent Capital BDC (CCAP) with Buy RecommendationOctober 1, 2024 | msn.comCrescent Capital: It Has Become A Better Buy After Q1 2024May 29, 2024 | seekingalpha.comCrescent Capital BDC, Inc. (NASDAQ:CCAP) Q1 2024 Earnings Call TranscriptMay 10, 2024 | msn.comSee More Headlines CCAP Stock Analysis - Frequently Asked Questions How have CCAP shares performed this year? CORESTATE Capital's stock was trading at €0.36 at the beginning of the year. Since then, CCAP stock has decreased by 23.6% and is now trading at €0.28. What other stocks do shareholders of CORESTATE Capital own? Based on aggregate information from My MarketBeat watchlists, some other companies that CORESTATE Capital investors own include bluebird bio (BLUE), Cisco Systems (CSCO), AbbVie (ABBV), Allena Pharmaceuticals (ALNA), ARAVIVE (ARAV), Athersys (ATHX) and Atara Biotherapeutics (ATRA). Industry, Sector and Symbol Stock ExchangeETR SectorReal Estate Industry Real Estate Services Sub-IndustryFinancial Services Current SymbolETR:CCAP CIKN/A Webwww.corestate-capital.ch Phone352 26 6372 20FaxN/AEmployees446Year FoundedN/AProfitability EPS (Trailing Twelve Months)(€21.10) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth-0.01Net Income-€3.50 billion Net Margins-1,143.36% Pretax MarginN/A Return on Equity-269.30% Return on Assets-7.35% Debt Debt-to-Equity RatioN/A Current RatioN/A Quick Ratio0.17 Sales & Book Value Annual Sales€306.04 million Price / Sales0.15 Cash Flow€0.46 per share Price / Cash Flow0.60 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares165,831,023Free FloatN/AMarket Cap€45.60 million OptionableNot Optionable Beta1.03 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (ETR:CCAP) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe mainstream media is wrong about AI — againThe mainstream media got it wrong … yet again. AI has recently turned the tech world on its head. And th...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CORESTATE Capital Holding S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share CORESTATE Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
